This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
News FDA Updates Law and Advocacy Technology Trends Viewpoints All News Media In-Depth Insights Pharmacist View Script-Ed Expert Interviews Podcasts Conferences Conference Coverage Conference Listing Resources Disease Awareness White Board Video American Pharmacists Month Sponsored Resources CME/CE Partners Publications Drug Topics Journal Total Pharmacy Journal Submission of Articles Events Virtual Events Total Pharmacy Solutions Summit Business Business Strategies Patient Services Pharmacy Inv
The United States leads the world in the research and development, manufacturing and access of innovative medicines. Today, more than half of global biopharmaceutical research and development happens in the United States alone. That’s not by accident: America’s innovation ecosystem is the best in the world, thanks to a policy environment that incentivizes innovation and rewards progress, and it supports workers, the economy and our patients.
Researchers investigated Norwegian pharmacists to understand their expertise, and potential knowledge gaps, regarding issues of epilepsy and treatment using antiseizure medication.
The staff of two world-class laboratories at the Centers for Disease Control and Prevention that were slated to be closed in a round of cuts announced in April have been informed that their terminations have been canceled. The CDC’s sexually transmitted disease laboratory and its viral hepatitis laboratory were targets of layoffs initiated by the U.S.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Amina Abubakar, PharmD, AAHIVP, joined Drug Topics to discuss her career journey as an independent pharmacy owner and the ways in which she’s been able to grow her business.
Zahra Mahmoudjafari, PharmD, MBA, BCOP, FHOPA, co-chair of the 2025 Oncology Pharmacists Connect (OPC) meeting, discusses what makes the event unique, highlights key sessions, and shares her excitement for the educational and networking opportunities.
Researchers wanted to address the potential impact of pharmacist-led influenza immunization services on vaccine uptake in older adults living in Denmark.
Researchers wanted to address the potential impact of pharmacist-led influenza immunization services on vaccine uptake in older adults living in Denmark.
The U.S. Food and Drug Administration (FDA) has approved Widaplik, a new triple combination medication designed to treat high blood pressure in adults. Widaplik is the first single pill containing three different drugs approved as an initial treatment for hypertension. It’s a huge win for people who would otherwise likely need several different prescriptions to optimize their cardiovascular health.
NEW YORK — All 17 experts recently dismissed from a government vaccine advisory panel published an essay Monday decrying “destabilizing decisions” made by U.S. Health Secretary Robert F. Kennedy Jr. that could lead to more preventable disease spread. Kennedy last week announced he would “retire” the entire panel that guides U.S. vaccine policy.
Explore the evolving role of pharmacists in patient care, emphasizing personalized services, community health, and innovative solutions for better health outcomes.
In an industry defined by compliance, complexity, and fierce competition, connecting with healthcare professionals (HCPs) effectively is both an art and a science. That’s where HCP targeting comes in—an evolving pillar of pharmaceutical marketing that blends precision, personalization, and performance. Pharma brands know that not all doctors are equal when it comes to prescribing behavior, influence, or engagement preferences.
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Manish Agrawal, MD, discusses emerging research on psychedelic-assisted therapy for patients with cancer, including innovative dyadic treatment models, challenges in capturing meaningful outcomes, and growing interest in integrating psychedelics into oncology and palliative care.
Pharmaceutical advertising has always been complex. From regulatory hurdles to evolving consumer expectations, the space demands constant adaptation. As we move deeper into 2025, brands are navigating a rapidly transforming landscape. Pharmaceutical advertising is no longer just about branded TV spots or full-page journal ads—it’s about omnichannel engagement, data-driven strategies, and personalized experiences.
Shilpa Biocare, a wholly owned subsidiary of Shilpa Medicare, has signed a commercial supply agreement with Finland-based Orion Corporation for its recombinant human albumin. The agreement, announced ahead of the BIO International Convention in Boston, US, grants Orion exclusive rights to distribute, market and sell the product across Europe. Recombinant human Aabumin is a synthetic […] The post Shilpa Medicare and Orion partner, expanding into European market appeared first on Pharmafile.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
The Royal Pharmaceutical Society (RPS) has appointed a new director for England who is ‘passionate about delivering high quality patient care and advocating on behalf of the profession’. Amandeep Doll, a specialist medical pharmacist at Nottingham University Hospital Trust , and current head of engagement and professional belonging at the RPS, will take up the new role in August this year.
Swiss biopharma, Roche, has announced its decision to proceed with phase 3 trials of prasinezumab, an investigational therapy for Parkinson’s disease. This decision is influenced by positive data from the phase 2b PADOVA study, ongoing open-label extensions (OLEs) of PADOVA as well as phase 2 PASADENA studies. Multiple endpoints from the PADOVA and OLE studies […] The post Roche advances treatment for Parkinson’s disease appeared first on Pharmafile.
Supernus Pharmaceuticals will snap up Sage Therapeutics, which was once valued at more than $9 billion, for $561 million up front, with the hope that it can help transform a newly launched treatment for postpartum depression into the indication's standard of care.
Many uninsured and underinsured individuals remain unaware of vital financial assistance programs for prescription costs, highlighting a critical need for increased awareness and resources.
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
In the third part of her Pharma Commerce video interview, Kirsten Newquist, Identiv’s CEO, shares the ways in which regulations, including DSCSA, are impacting the adoption of smarter packaging technologies across the industry.
A central theme in Humana’s plan for boosting Medicare Advantage profitability in the future is a strategy its peers have relied on for over a decade: coaxing members in for their annual wellness visits. The Medicare Advantage business has come under fire in recent months for its outsized impact on the federal budget, and the potentially billions of dollars that could come from limiting insurers’ tactics for maximizing their government payments.
Elevated blood cholesterol levels are a primary risk factor for cardiovascular disease. Healthcare professionals monitor risk factors such as cholesterol levels in the blood and make appropriate recommendations to reduce the risk of major events such as stroke and heart attack. While reducing cholesterol starts with a healthy diet and exercise, many Americans will need pharmaceutical therapy to lower their cholesterol levels and risk of heart disease.
Certain gastrointestinal disorders share microbial biomarkers, a study finds, with researchers predicting the discovery could lead to new diagnostic tools to aid early detection. Gastrointestinal disorders affected nearly 40% of the global population, with gut microbiome-metabolome interactions known to play a crucial role in gastric cancer, colorectal cancer and inflammatory bowel disease (IBD), researchers wrote in the Journal of Translational Medicine.
Democrats in the House and Senate have introduced a new bill that would establish a new "Part E" for Medicare that will allow people to opt into the program.
Topiramate , also sold under the brand names Topamax and Trokendi XR , is a prescription drug approved by the Food and Drug Administration (FDA) for the treatment of seizure disorders, such as epilepsy. It is also used to help manage migraine headaches, as a mood stabilizer in psychiatric patients, and for chronic weight management. It has a number of off-label uses, such as treating substance use disorders.
UCB is planning a major manufacturing investment that is expected to provide a significant economic impact of approximately $5 billion in the US. The biopharmaceutical company intends to expand its biologics manufacturing capacity with a new facility in the country. This supports future medicine delivery and a more resilient and sustainable supply chain, according to UCB.
Following a turbulent few years, Sage Therapeutics has reached an agreement with Maryland-based Supernus Pharmaceuticals, which will acquire the Cambridge, Mass., biotech in a deal that could be worth up to $795 million, the companies announced Monday. The deal is expected to close in the third quarter of this year. “This transaction follows a comprehensive strategic review by our Board of Directors, and I am confident this deal maximizes value for shareholders,” Sage CEO Bar
Janssen-Cilag, a Johnson & Johnson company, has announced results from a matching-adjusted indirect comparison presented at this year’s European Hematology Association Congress in Milan, Italy. It suggested that fixed-duration ibrutinib plus venetoclax (I+V) is more effective than acalabrutinib plus venetoclax (A+V) in previously untreated chronic lymphocytic leukaemia (CLL), a slow-growing blood cancer of the white […] The post Johnson & Johnson presents promising data on le
The biopharma company—whose US headquarters is in Atlanta—will be building a new biologics manufacturing facility in a city to be named at a later date.
The researcher, mentor, startup founder and prominent voice on the use of biomedical data and AI in healthcare had been battling cancer for two and a half years.
Austin Read of Thermo Fisher Scientific discusses how combining biospecimens with real-world data is advancing diagnostics, treatment and the future of patient care.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
465 
Let's personalize your content